We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.49B
AUM Growth
-$343M
(-3.9%)
Cap. Flow
-$249M
Cap. Flow
% of AUM
-2.94%
Top 10 Holdings %
Top 10 Hldgs %
16.07%
Holding
2,271
New
51
Increased
125
Reduced
935
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25.3M |
| 2 |
Baxter International
BAX
|
+$9.74M |
| 3 |
Archer Daniels Midland
ADM
|
+$6.88M |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$6.54M |
| 5 |
Nektar Therapeutics
NKTR
|
+$4.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$17.1M |
| 2 |
Apple
AAPL
|
+$10.6M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$10.1M |
| 4 |
AvalonBay Communities
AVB
|
+$7.62M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$6.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.14% |
| 2 | Financials | 17.01% |
| 3 | Healthcare | 12.77% |
| 4 | Industrials | 11.29% |
| 5 | Consumer Discretionary | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Teva Pharmaceuticals
TEVA
$42.6B
| $1.07M | 0.01% |
62,753
-7,700
| -11% | -$150K |
|
|
DO
977
DELISTED
Diamond Offshore Drilling
DO
| $1.07M | 0.01% |
73,020
-558
| -0.8% | -$9.22K |
|
|
CLVS
978
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.07M | 0.01% |
20,203
| – | – |
|
979
Ormat Technologies
ORA
$6.98B
| $1.06M | 0.01% |
18,869
| – | – |
|
980
RLI Corp
RLI
$5.87B
| $1.06M | 0.01% |
33,506
| – | – |
|
981
Pebblebrook Hotel Trust
PEB
$2.05B
| $1.06M | 0.01% |
30,891
| – | – |
|
982
Itron
ITRI
$4.5B
| $1.06M | 0.01% |
14,816
-1,398
| -9% | -$100K |
|
|
SJI
983
DELISTED
South Jersey Industries, Inc.
SJI
| $1.06M | 0.01% |
37,607
| – | – |
|
984
Lithia Motors
LAD
$8.32B
| $1.06M | 0.01% |
10,519
| – | – |
|
985
Merit Medical Systems
MMSI
$5.4B
| $1.06M | 0.01% |
23,310
| – | – |
|
|
ODP
986
DELISTED
ODP
ODP
| $1.06M | 0.01% |
49,134
-4,970
| -9% | -$146K |
|
|
MDCO
987
DELISTED
Medicines Co
MDCO
| $1.05M | 0.01% |
32,038
| – | – |
|
988
Unifirst Corp
UNF
$5.21B
| $1.05M | 0.01% |
6,518
-669
| -9% | -$107K |
|
989
Mercury Insurance
MCY
$5.81B
| $1.04M | 0.01% |
22,790
-316
| -1% | -$15.1K |
|
990
PENN Entertainment
PENN
$2.53B
| $1.04M | 0.01% |
39,722
| – | – |
|
991
Axos Financial
AX
$5.72B
| $1.04M | 0.01% |
25,659
-2,505
| -9% | -$91.3K |
|
992
Navient
NAVI
$867M
| $1.04M | 0.01% |
79,150
-2,228
| -3% | -$30.3K |
|
993
World Kinect Corp
WKC
$1.9B
| $1.04M | 0.01% |
42,213
-570
| -1% | -$14.7K |
|
|
AXE
994
DELISTED
Anixter International Inc
AXE
| $1.03M | 0.01% |
13,642
| – | – |
|
995
Ultragenyx Pharmaceutical
RARE
$2.6B
| $1.03M | 0.01% |
20,122
+1,807
| +10% | +$91K |
|
|
NEWR
996
DELISTED
New Relic, Inc.
NEWR
| $1.03M | 0.01% |
13,849
| – | – |
|
997
Teladoc Health
TDOC
$1.26B
| $1.02M | 0.01% |
25,351
| – | – |
|
998
Columbia Sportswear
COLM
$2.96B
| $1.02M | 0.01% |
13,362
| – | – |
|
999
Simpson Manufacturing
SSD
$8B
| $1.02M | 0.01% |
17,678
-1,820
| -9% | -$105K |
|
|
SRCI
1000
DELISTED
SRC Energy Inc
SRCI
| $1.02M | 0.01% |
107,906
| – | – |
|
Similar funds
PCM
HHII
EIM
P
BPA
NAM
MIC
MetLife Investment Management's Q1 2018 Portfolio in Review
As of Q1 2018, MetLife Investment Management held 2,271 positions worth $8.49B, down 3.9% from $8.84B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
MetLife Investment Management's Q1 2018 filing shows 51 new, 125 increased, 935 reduced and 90 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M. The largest sale was Bank of New York Mellon, an estimated $17.1M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- MetLife Investment Management's largest Q1 2018 buy was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $25.3M increase.
- MetLife Investment Management's biggest Q1 2018 reduction was Apple, cutting an estimated $10.6M.
- MetLife Investment Management fully exited Bank of New York Mellon in Q1 2018, selling an estimated $17.1M.
- MetLife Investment Management's ten largest holdings make up 16% of its $8.49B portfolio in Q1 2018.
- MetLife Investment Management opened 51 new positions and closed 90 in Q1 2018.
- MetLife Investment Management's portfolio value fell 3.9% quarter-over-quarter to $8.49B.
Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.